In a multicenter, randomized, double-blind, placebo-controlled trial (J-EMPHASIS-HF) of eplerenone in Japanese patients with chronic heart failure (HFrEF), BNP was significantly higher in the eplerenone group than in the placebo group [26]. Here, NPPB is linked to congestive heart failure.